drugset
drugset / Trial / NCT00004604

Biological Therapy in Treating Patients With Metastatic Cancer

NCT00004604 ↗

Phase 1 Completed 24 enrolled Duke University National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of biological therapy in treating patients who have metastatic cancer that has not responded to previous treatment.

Timeline

Start
1997-02
Primary completion
2001-06
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CEA RNA-pulsed DC cancer vaccine Vaccine — Intravenous

Indications

bile duct cancer breast cancer colorectal cancer gallbladder cancer gastric cancer head and neck cancer lung cancer malignant pancreatic neoplasm metastatic malignant neoplasm ovarian cancer testicular germ cell tumor